1. Home
  2. AQST vs ORN Comparison

AQST vs ORN Comparison

Compare AQST & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • ORN
  • Stock Information
  • Founded
  • AQST 2004
  • ORN 1994
  • Country
  • AQST United States
  • ORN United States
  • Employees
  • AQST N/A
  • ORN N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • AQST Health Care
  • ORN Industrials
  • Exchange
  • AQST Nasdaq
  • ORN Nasdaq
  • Market Cap
  • AQST 390.4M
  • ORN 339.4M
  • IPO Year
  • AQST 2018
  • ORN 2007
  • Fundamental
  • Price
  • AQST $3.96
  • ORN $7.19
  • Analyst Decision
  • AQST Strong Buy
  • ORN Strong Buy
  • Analyst Count
  • AQST 7
  • ORN 2
  • Target Price
  • AQST $11.29
  • ORN $11.25
  • AVG Volume (30 Days)
  • AQST 1.1M
  • ORN 443.2K
  • Earning Date
  • AQST 08-11-2025
  • ORN 07-29-2025
  • Dividend Yield
  • AQST N/A
  • ORN N/A
  • EPS Growth
  • AQST N/A
  • ORN N/A
  • EPS
  • AQST N/A
  • ORN 0.27
  • Revenue
  • AQST $54,228,000.00
  • ORN $837,494,000.00
  • Revenue This Year
  • AQST N/A
  • ORN $4.34
  • Revenue Next Year
  • AQST $51.62
  • ORN $11.09
  • P/E Ratio
  • AQST N/A
  • ORN $26.10
  • Revenue Growth
  • AQST 5.29
  • ORN 15.85
  • 52 Week Low
  • AQST $2.12
  • ORN $4.64
  • 52 Week High
  • AQST $5.80
  • ORN $9.95
  • Technical
  • Relative Strength Index (RSI)
  • AQST 50.64
  • ORN 33.52
  • Support Level
  • AQST $3.73
  • ORN $6.91
  • Resistance Level
  • AQST $4.10
  • ORN $9.95
  • Average True Range (ATR)
  • AQST 0.22
  • ORN 0.54
  • MACD
  • AQST -0.07
  • ORN -0.19
  • Stochastic Oscillator
  • AQST 17.42
  • ORN 9.21

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: